查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1523029

基于水凝胶的药物传输系统市场报告：2030 年趋势、预测与竞争分析

Hydrogel-Based Drug Delivery System Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

基于水凝胶的药物传递系统的趋势和预测

到 2030 年，全球水凝胶给药系统市场预计将达到 112 亿美元，2024 年至 2030 年复合年增长率为 6.8%。此市场的主要驱动因素是药物输送系统研发投资的增加以及药物输送系统控制释放需求的增加。全球水凝胶给药系统市场的未来性充满希望，皮下、眼科和口服市场存在机会。

基于水凝胶的药物传输系统（按细分市场）

本报告按聚合物原料、递送途径和地区对全球水凝胶药物递送系统进行了预测。

基于水凝胶的药物传输系统市场洞察

Lucintel 预测，在预测期内，天然原料仍将是最大的细分市场，因为水凝胶在细胞黏附特性方面表现出有利的特性。

在这个市场中，眼科产品将继续成为最大的细分市场。

由于可以获得包含现代治疗费用的有效报销，北美在预测期内将继续成为最大的地区。

常问问题

Q1.市场规模为：

A1. 到 2030 年，基于水凝胶的药物输送系统的全球市场预计将达到 112 亿美元。

Q2.市场成长预测是多少：

A2. 2024年至2030年，以水凝胶为基础的药物传递系统的全球市场预计将以6.8%的复合年增长率成长。

Q3.影响市场成长的主要驱动因素是：

A3.此市场的主要驱动因素是药物输送系统研发投资的增加以及药物输送系统控制释放需求的增加。

Q4.市场的主要细分市场是：

A4. 以水凝胶为基础的药物传递系统市场未来性广阔，在皮下、眼科和口腔市场都有机会。

Q5.市场的主要企业是：

A5. 水凝胶给药系统的主要企业如下：

  • Galderma
  • Blairex Laboratories
  • Johnson & Johnson
  • Bausch and Lomb
  • Medtronic
  • Ocular Therapeutix
  • Ferring
  • Endo International
  • Akorn
  • Tolmar Pharmaceuticals

Q6.未来最大的细分市场是什么？

A6.Lucintel 预测，天然原料在预测期内将继续成为最大的细分市场，因为它们在细胞黏附特性方面表现出有利的特性。

Q7. 未来五年预计哪些地区的市场成长最大？

A7. 由于可以提供包含现代治疗费用的有效报销，预计北美在预测期内仍将是最大的地区。

Q8. 可以客製化报告吗？

A8. 是的，Lucintel 提供 10% 的客製化服务，无需额外付费。

目录

第一章执行摘要

第二章全球水凝胶给药系统市场：市场动态

  • 简介、背景、分类
  • 供应链
  • 产业驱动因素与挑战

第三章 2018-2030年市场趋势及预测分析

  • 宏观经济趋势（2018-2023）与预测（2024-2030）
  • 全球水凝胶给药系统市场趋势（2018-2023）与预测（2024-2030）
  • 聚合物原料水凝胶给药系统的全球市场
    • 自然的
    • 合成
    • 混合
  • 按递送途径分類的水凝胶药物递送系统的全球市场
    • 皮下的
    • 眼科
    • 口腔
    • 其他的

第四章 2018-2030年区域市场趋势及预测分析

  • 按地区分類的水凝胶给药系统市场
  • 北美水凝胶给药系统市场
  • 欧洲水凝胶给药系统市场
  • 亚太水凝胶给药系统市场
  • 其他区域性水凝胶给药系统市场

第五章 竞争分析

  • 产品系列分析
  • 营运整合
  • 波特五力分析

第六章 成长机会与策略分析

  • 成长机会分析
    • 聚合物原料的全球水凝胶给药系统市场成长机会
    • 基于水凝胶的药物递送系统按递送途径的市场成长机会
    • 全球水凝胶给药系统市场成长机会（按地区）
  • 全球水凝胶给药系统市场的新趋势
  • 战略分析
    • 新产品开发
    • 扩大全球水凝胶给药系统市场的产能
    • 全球水凝胶给药系统市场的合併、收购与合资企业
    • 认证和许可

第七章主要企业概况

  • Galderma
  • Blairex Laboratories
  • Johnson & Johnson
  • Bausch and Lomb
  • Medtronic
  • Ocular Therapeutix
  • Ferring
  • Endo International
  • Akorn
  • Tolmar Pharmaceuticals
简介目录

Hydrogel-Based Drug Delivery System Trends and Forecast

The future of the global hydrogel-based drug delivery system market looks promising with opportunities in the subcutaneous, ocular, and oral cavity markets. The global hydrogel-based drug delivery system market is expected to reach an estimated $11.2 billion by 2030 with a CAGR of 6.8% from 2024 to 2030. The major drivers for this market are increasing investment in research and development for drug delivery systems and growing demand for controlled release of drug delivery systems.

A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.

Hydrogel-Based Drug Delivery System by Segment

The study includes a forecast for the global hydrogel-based drug delivery system by polymer origin, route, and region.

Hydrogel-Based Drug Delivery System Market by Polymer Origin [Shipment Analysis by Value from 2018 to 2030]:

  • Natural
  • Synthetic
  • Hybrid

Hydrogel-Based Drug Delivery System Market by Route [Shipment Analysis by Value from 2018 to 2030]:

  • Subcutaneous
  • Ocular
  • Oral Cavity
  • Others

Hydrogel-Based Drug Delivery System Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Hydrogel-Based Drug Delivery System Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies hydrogel-based drug delivery system companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the hydrogel-based drug delivery system companies profiled in this report include-

  • Galderma
  • Blairex Laboratories
  • Johnson & Johnson
  • Bausch and Lomb
  • Medtronic
  • Ocular Therapeutix
  • Ferring
  • Endo International
  • Akorn
  • Tolmar Pharmaceuticals

Hydrogel-Based Drug Delivery System Market Insights

Lucintel forecasts that natural will remain the largest segment over the forecast period as they exhibit favorable traits for cell adhesion properties.

Within this market, ocular will remain the largest segment.

North America will remain the largest region over the forecast period due to availability of effective reimbursement that encompasses the costs of contemporary treatments.

Features of the Global Hydrogel-Based Drug Delivery System Market

Market Size Estimates: Hydrogel-based drug delivery system market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Hydrogel-based drug delivery system market size by polymer origin, route, and region in terms of value ($B).

Regional Analysis: Hydrogel-based drug delivery system market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different polymer origin, routes, and regions for the hydrogel-based drug delivery system market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the hydrogel-based drug delivery system market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the hydrogel-based drug delivery system market size?

Answer: The global hydrogel-based drug delivery system market is expected to reach an estimated $11.2 billion by 2030.

Q2. What is the growth forecast for hydrogel-based drug delivery system market?

Answer: The global hydrogel-based drug delivery system market is expected to grow with a CAGR of 6.8% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the hydrogel-based drug delivery system market?

Answer: The major drivers for this market are increasing investment in research and development for drug delivery systems and growing demand for controlled release of drug delivery systems.

Q4. What are the major segments for hydrogel-based drug delivery system market?

Answer: The future of the hydrogel-based drug delivery system market looks promising with opportunities in the subcutaneous, ocular, and oral cavity markets.

Q5. Who are the key hydrogel-based drug delivery system market companies?

Answer: Some of the key hydrogel-based drug delivery system companies are as follows:

  • Galderma
  • Blairex Laboratories
  • Johnson & Johnson
  • Bausch and Lomb
  • Medtronic
  • Ocular Therapeutix
  • Ferring
  • Endo International
  • Akorn
  • Tolmar Pharmaceuticals

Q6. Which hydrogel-based drug delivery system market segment will be the largest in future?

Answer: Lucintel forecasts that natural will remain the largest segment over the forecast period as they exhibit favorable traits for cell adhesion properties.

Q7. In hydrogel-based drug delivery system market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to availability of effective reimbursement that encompasses the costs of contemporary treatments.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the hydrogel-based drug delivery system market by polymer origin (natural, synthetic, and hybrid), route (subcutaneous, ocular, oral cavity, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Hydrogel-Based Drug Delivery System Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Hydrogel-Based Drug Delivery System Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Hydrogel-Based Drug Delivery System Market by Polymer Origin
    • 3.3.1: Natural
    • 3.3.2: Synthetic
    • 3.3.3: Hybrid
  • 3.4: Global Hydrogel-Based Drug Delivery System Market by Route
    • 3.4.1: Subcutaneous
    • 3.4.2: Ocular
    • 3.4.3: Oral Cavity
    • 3.4.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Hydrogel-Based Drug Delivery System Market by Region
  • 4.2: North American Hydrogel-Based Drug Delivery System Market
    • 4.2.1: North American Hydrogel-Based Drug Delivery System Market by Polymer Origin: Natural, Synthetic, and Hybrid
    • 4.2.2: North American Hydrogel-Based Drug Delivery System Market by Route: Subcutaneous, Ocular, Oral Cavity, and Others
  • 4.3: European Hydrogel-Based Drug Delivery System Market
    • 4.3.1: European Hydrogel-Based Drug Delivery System Market by Polymer Origin: Natural, Synthetic, and Hybrid
    • 4.3.2: European Hydrogel-Based Drug Delivery System Market by Route: Subcutaneous, Ocular, Oral Cavity, and Others
  • 4.4: APAC Hydrogel-Based Drug Delivery System Market
    • 4.4.1: APAC Hydrogel-Based Drug Delivery System Market by Polymer Origin: Natural, Synthetic, and Hybrid
    • 4.4.2: APAC Hydrogel-Based Drug Delivery System Market by Route: Subcutaneous, Ocular, Oral Cavity, and Others
  • 4.5: ROW Hydrogel-Based Drug Delivery System Market
    • 4.5.1: ROW Hydrogel-Based Drug Delivery System Market by Polymer Origin: Natural, Synthetic, and Hybrid
    • 4.5.2: ROW Hydrogel-Based Drug Delivery System Market by Route: Subcutaneous, Ocular, Oral Cavity, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Hydrogel-Based Drug Delivery System Market by Polymer Origin
    • 6.1.2: Growth Opportunities for the Global Hydrogel-Based Drug Delivery System Market by Route
    • 6.1.3: Growth Opportunities for the Global Hydrogel-Based Drug Delivery System Market by Region
  • 6.2: Emerging Trends in the Global Hydrogel-Based Drug Delivery System Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Hydrogel-Based Drug Delivery System Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Hydrogel-Based Drug Delivery System Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Galderma
  • 7.2: Blairex Laboratories
  • 7.3: Johnson & Johnson
  • 7.4: Bausch and Lomb
  • 7.5: Medtronic
  • 7.6: Ocular Therapeutix
  • 7.7: Ferring
  • 7.8: Endo International
  • 7.9: Akorn
  • 7.10: Tolmar Pharmaceuticals